Rezultati pretraživanja
  1. My valuations is at $3.46. Waiting for it to come down.

  2. Spiked to 4.22 pm, new analyst pt $10.

  3. prije 14 sati

    JMP Favorablerisk/rewardheadingintofirstinhumandataofRNAiagentAB-729 in late 1Q prompts us to upgrade our rating to Market Outperform from Market Perform with a $10 risk-adjusted, DCF-derived price target on Arbutus Biopharma.

  4. risk .03 reward $.09+

  5. Odgovor korisniku/ci

    This explains yesterday’s movement. Someone leaked. Is this not trading on ‘material non public information’ in violation of the law? Where’s the SEC?

  6. prije 15 sati

    PM Up Gappers (Mid / Large Float):

  7. prije 15 sati

    2/5 Pre-Market Gainers : +132.49% : +35.23% : +29.13% : +22.56% : +15.66% : +14.33% : +14.26% : +11.71% : +10.34% : +9.99% Losers : -32.22% : -17.80% : -10.25% : -10.25% : -9.28% : -4.07%

  8. prije 16 sati

    is up 15.66% on 161,316 volume. Now trading at $3.25.

  9. prije 17 sati

    Good Morning some gappers pre market &

  10. prije 18 sati

    - JMP Securities upgrades to Outperform with $10 PT

  11. 3. velj

    This one getting ready to make a move out of trips. Call the company they are excited for what's ahead $$

  12. 3. velj

    up double digits in Pre market trading, as I mentioned, these stocks are on serious momentum.

  13. 1. velj

    exactly don't sell -6.45 % change recently

  14. 31. sij

    and genevant sub have nebulizing RNAi and antiviral know-how, but guess no need to hype if they sit on decent HBV data.

  15. 30. sij

    crisis watchlist for pharma stocks $23.5 $4.09 $7 $2.70 for potential 100%+ gainz in the next coming days/months. 🦇☣️

  16. 30. sij

    Sorrento and seems like scammers. tight float is the only reason this is up, rest of pipeline is an equivalent and wont compete with /JNJ

  17. 30. sij

    Roche drops antisense HBV. Good for . , , ,

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.